Stellar, Araclon sign KLH supply deal for clinical trials in Alzheimer’s active immunotherapies
Stellar is a manufacturer of KLH, an immune-stimulating protein widely used as a carrier molecule in the development of immunotherapies. Spain-based Araclon is majority-owned by global healthcare firm